首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1457993

全球髂动脉支架市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Iliac Stent Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球髂动脉支架市场需求预计将从2023年的16亿美元达到2032年近27.7亿美元的市场规模，2024-2032年研究期间CAGR为6.29%。

髂动脉支架是一种插入髂动脉的小型网状管，用于治疗週边动脉疾病 (PAD) 等疾病。这些支架透过为动脉提供结构支撑、防止阻塞和改善骨盆区域的循环来帮助恢復血流。放置这种支架是一种常见的医疗干预措施，用于缓解与血流减少相关的腿部疼痛和痉挛等症状。

市场动态

髂动脉支架市场主要是由周边动脉疾病（PAD）盛行率不断上升所推动的，特别是在老年人口中，通常用于治疗髂动脉狭窄或阻塞。此外，支架设计、材料和输送系统的持续技术进步有助于提高疗效和安全性，吸引医疗保健提供者和患者。鑑于老年人血管疾病的发生率较高，全球人口老化也增加了对髂支架的需求。此外，与传统的开放性手术选择相比，由于恢復时间缩短和发病率较低，人们对微创手术（例如髂动脉支架置入术等血管内介入治疗）的偏好正在上升。最后，对周围血管疾病的认识提高和诊断技术的进步有助于早期发现和治疗，进一步推动市场。然而，与髂支架手术和设备相关的高成本可能会阻碍市场成长。这种经济障碍可能会限制采用，特别是在财政拮据或医疗基础设施不足的地区，从而影响市场的成长潜力。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球髂支架市场的各个细分市场进行了包容性评估。髂支架产业的成长和趋势为本研究提供了整体方法。

市场区隔

髂支架市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

自扩张支架
球囊扩张支架
其他的

依动脉病变分类

髂总动脉病变
严重钙化病变
完全性阻塞性病变

按最终用途

医院
门诊设施
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区髂动脉支架市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

全球髂动脉支架市场占有率（按地区）（代表性图）
全球髂动脉支架市场份额

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。髂动脉支架市场的主要参与者包括 BD、雅培、波士顿科学公司、WL Gore & Associates, Inc.、库克、美敦力、iVascular、Terumo Corporation、Biotronik SE & Co KG、Getinge AB。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：髂动脉支架公司的竞争格局

髂动脉支架市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
BD

公司简介
公司收入
产品
最近的发展

Abbott

公司简介
公司收入
产品
最近的发展

Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

WL Gore & Associates Inc.

公司简介
公司收入
产品
最近的发展

Cook

公司简介
公司收入
产品
最近的发展

Medtronic

公司简介
公司收入
产品
最近的发展

iVascular

公司简介
公司收入
产品
最近的发展

Terumo Corporation

公司简介
公司收入
产品
最近的发展

Biotronik SE & Co KG

公司简介
公司收入
产品
最近的发展

Getinge AB.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113948

The global demand for Iliac Stent Market is presumed to reach the market size of nearly USD 2.77 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 6.29% under the study period 2024 - 2032.

An Iliac stent is a small, mesh-like tube inserted into the iliac arteries to treat conditions like peripheral artery disease (PAD). These stents help restore blood flow by providing structural support to the arteries, preventing blockages, and improving circulation in the pelvic region. Placement of this stent is a common medical intervention to alleviate symptoms such as leg pain and cramping associated with reduced blood flow.

MARKET DYNAMIC

The Iliac stent market is primarily driven by the escalating prevalence of peripheral artery disease (PAD), particularly among the aging population, commonly used to treat iliac artery stenosis or occlusion. Furthermore, ongoing technological advancements in stent design, materials, and delivery systems contribute to improved efficacy and safety, attracting healthcare providers and patients. The growing aging demographic globally also enhances the demand for Iliac stents, given the higher incidence of vascular diseases in older individuals. Furthermore, the preference for minimally invasive procedures, such as endovascular interventions like Iliac stenting, is on the rise due to reduced recovery times and lower morbidity rates compared to traditional open surgical options. Lastly, improved awareness of peripheral vascular diseases and advancements in diagnostic techniques contribute to early detection and treatment, further driving the market. However, the high cost associated with Iliac stent procedures and devices may hamper the market growth. This economic barrier may limit adoption, particularly in regions with financial constraints or inadequate healthcare infrastructure, thus impacting the market's growth potential.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of iliac stent. The growth and trends of iliac stent industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the iliac stent market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Self-Expandable Stents
Balloon-Expandable Stents
Others

By Artery Lesions

Common Iliac Artery Lesions
Severe Calcified Lesions
Complete Obstructive Lesions

By End-Use

Hospitals
Outpatient Facilities
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Iliac Stent market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL ILIAC STENT MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Iliac Stent Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Iliac Stent market include BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Cook, Medtronic, iVascular, Terumo Corporation, Biotronik SE & Co KG, Getinge AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ILIAC STENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Artery Lesions
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ILIAC STENT MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Self-Expandable Stents Historic and Forecast Sales by Regions
5.5 Balloon-Expandable Stents Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ILIAC STENT MARKET ANALYSIS BY ARTERY LESIONS

6.1 Overview by Artery Lesions
6.2 Historical and Forecast Data
6.3 Analysis by Artery Lesions
6.4 Common Iliac Artery Lesions Historic and Forecast Sales by Regions
6.5 Severe Calcified Lesions Historic and Forecast Sales by Regions
6.6 Complete Obstructive Lesions Historic and Forecast Sales by Regions

7 . GLOBAL ILIAC STENT MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Outpatient Facilities Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ILIAC STENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ILIAC STENT COMPANIES

9.1. Iliac Stent Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF ILIAC STENT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BD
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbott
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Boston Scientific Corporation
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. W. L. Gore & Associates Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Cook
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Medtronic
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. iVascular
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Terumo Corporation
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Biotronik SE & Co KG
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Getinge AB.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments